Hepatic complications of hematopoietic cell transplantation
- PMID: 17335679
- DOI: 10.1007/s11894-008-0022-y
Hepatic complications of hematopoietic cell transplantation
Abstract
Acute and chronic liver disease contributes significantly to morbidity and mortality following hematopoietic cell transplantation (HCT). The best prognostic indicator for the development of severe liver dysfunction is an early rise in liver function test results after HCT. The leading causes soon after HCT are acute graft-versus-host disease (GVHD), sinusoidal obstruction syndrome, drug and total parenteral nutrition hepatotoxicity, sepsis, and viral infection. Hepatic herpesvirus and fungal infections after HCT, though uncommon, can be life-threatening and warrant immediate diagnosis and treatment. Hepatitis B, hepatitis C virus, iron overload, and chronic GVHD are among the most common causes for chronic liver disease after HCT. Because treatments are directed at the underlying etiology of liver disease, prompt diagnosis by means of laboratory tests, hepatic imaging, and often liver biopsy is required after HCT.
Similar articles
-
Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.Hepatology. 2010 Apr;51(4):1450-60. doi: 10.1002/hep.23533. Hepatology. 2010. PMID: 20373370 Free PMC article. Review.
-
Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience.J Egypt Natl Canc Inst. 2020 Feb 22;32(1):11. doi: 10.1186/s43046-020-0020-1. J Egypt Natl Canc Inst. 2020. PMID: 32372257
-
A systematic approach to hepatic complications in hematopoietic stem cell transplantation.J Hematother Stem Cell Res. 2002 Apr;11(2):215-29. doi: 10.1089/152581602753658420. J Hematother Stem Cell Res. 2002. PMID: 11983095 Review.
-
Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose.Hum Pathol. 2023 Nov;141:170-182. doi: 10.1016/j.humpath.2023.07.007. Epub 2023 Aug 2. Hum Pathol. 2023. PMID: 37541449
-
The hepatologist in the haematologists' camp.Br J Haematol. 2001 Jun;113(3):567-78. doi: 10.1046/j.1365-2141.2001.02628.x. Br J Haematol. 2001. PMID: 11380440 Review. No abstract available.
Cited by
-
Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD).J Gastrointest Oncol. 2016 Apr;7(Suppl 1):S21-31. doi: 10.3978/j.issn.2078-6891.2015.036. J Gastrointest Oncol. 2016. PMID: 27034810 Free PMC article. Review.
-
Late Effects Following Hematopoietic Stem Cell Transplantation Among Childhood Transplant Survivors with Fanconi Anemia.Turk J Haematol. 2025 Feb 28;42(1):15-24. doi: 10.4274/tjh.galenos.2024.2024.0189. Epub 2024 Nov 8. Turk J Haematol. 2025. PMID: 39513346 Free PMC article.
-
Drug-induced liver injury after allogeneic bone marrow transplantation.Int J Hematol. 2013 Oct;98(4):499-503. doi: 10.1007/s12185-013-1434-5. Epub 2013 Sep 15. Int J Hematol. 2013. PMID: 24037455
-
Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.Cancer Res Treat. 2016 Jul;48(3):990-7. doi: 10.4143/crt.2015.296. Epub 2016 Jan 14. Cancer Res Treat. 2016. PMID: 26790967 Free PMC article.
-
Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.Radiat Oncol. 2012 May 3;7:67. doi: 10.1186/1748-717X-7-67. Radiat Oncol. 2012. PMID: 22553982 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical